DIABETES TREATMENT AND MANAGEMENT
Tracking # 20-363717
Course overview
The goal of this program is to enhance healthcare professional's ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to: Describe the roles of amylin and the human incretin hormone GLP-1 in regulating blood glucose levels.Identify three benefits of pramlintide acetate (Symlin) and exenatide (Byetta) injection therapy.Discuss three interventions to help patients adjust to and properly use pramlintide or exenatide therapy.
Subject areas
This course counts toward the state boards and subject areas below.
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Doctor of Osteopathy
1h
AMA Category I
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I
Doctor of Osteopathic Medicine
1h
AMA Category I